These findings are consistent with the view that PDI expression is clearly linked to ALS pathology and either de-nitrosylation of PDI or up-regulation of total PDI may provide a therapeutic benefit in ALS. The gene discussed is P4HB; the disease is amyotrophic lateral sclerosis.